Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG)--results from a prospective randomized multicenter trial.

OBJECTIVE: To determine the efficacy of antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) as a part of a standardized regimen. METHODS: An open prospective randomised multicenter study in 216 patients. 106 received ceftriaxone 1 g i.v. 30 min preinterventionally and 110 no study medication. A standardized protocol was followed for PEG preparation, insertion, and aftercare; all patients received a 15 French gastrostomy tube. Follow-up of local and systemic infection and clinical course was continued to postintervention day 10. An aggregate erythema and exudation score > 3 or the presence of pus was taken as indicative of peristomal infection. The pharmacoeconomics of antibiotic use were also examined. RESULTS: In no-prophylaxis patients, wound infection rates were 23.6% on day 4 and 24.5% on day 10 vs. 7.6% (p < 0.05) and 11.4% (p < 0.05), respectively, in prophylaxis patients. Results were disproportionally better in tumor patients in comparison with neurological patients. Patients systemic infection rates were 11.8% vs. 1.9% in noprophylaxis vs. prophylaxis (p < 0.05), and overall infection rates 36.3% vs. 13.3%, respectively (p < 0.05). Pneumonia was more frequent in patients with underlying neurological disease and reduced in the prophylaxis group. Antibiotic and application costs were similar in both groups (p = 0.400). CONCLUSIONS: Single-dose ceftriaxone 1 g is a effective prophylaxis against local and systemic infection after PEG and should be a part of a standard regimen.

Behavioural changes and bioelectric brain maturation of preterm and fullterm newborn infants: a polygraphic study.

Fifty-two preterm and fullterm infants requiring assisted ventilation were observed and examined polygraphically. In addition, 24 preterm infants without prenatal or perinatal complications and not needing assisted ventilation were examined polygraphically in order to validate a special method of differentiating sleep states and sleep cycles. State criteria were EEG records, eye movements and gross body movements. Using this evaluation method, all 14 low-risk preterm infants showed stable sleep states and cycles, as did 16 of 23 high-risk preterm and 10 of 15 high-risk fullterm infants. 11 high-risk preterm and fullterm infants were found to have extremely unstable sleep states, or were comatose. The EEG could not be evaluated in only one case. Infants requiring assisted ventilation showed the following changes in comparison with the infants who did not need ventilation: the percentage of quiet sleep increased significantly; the percentage of indeterminate sleep increased as a sign of more unstable behaviour; and the individual measurements of the recorded and observed variables showed wider variability. Bioelectric brain maturation decreased significantly with increasing risk among both preterm and fullterm infants given assisted ventilation.

Acute monocytic leukemia complicating combined-modality therapy for localized childhood Ewing's sarcoma.

Rapidly fatal acute monocytic leukemia occurred in an 11-year-old by 33 months after the beginning of irradiation and chemotherapy for non-metastatic pelvic Ewing's sarcoma. At autopsy, no recurrent primary disease was seen. An analysis of this case together with a review of the literature suggests therapy-related leukemogenesis. Thus, the decline in mortality rate for childhood cancer may be accompanied by an increased incidence of second neoplasms in cured children having the potential of a normal life span.